IO Biotech Corp - IOBT Net earnings per share for the last four quarters

Official company branding of IO Biotech Corp (IOBT)

IO Biotech, Inc. (IOBT) develops advanced vaccines against melanoma and solid tumors, mitigating risks through the variability of its clinical programs. The business model is independent of economic cycles, with key triggers tied to medical reports. The market dynamics of the securities based on EPS (TTM) are currently fixed at 2.40. The company's growth relies on strategic alliances with pharmaceutical behemoths to conduct joint trials.

IO Biotech (IOBT) Earnings per share for the last twelve months: for the period 02/11/2024 - 04/18/2026

IOBT (IO Biotech Corp): analytical breakdowns and indicator data

- current price and projected stock value:
Price Performance Chart iobiotech.com|IOBT - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization IO Biotech Inc|IOBT - Total Company Value
- book value of equity indicators:
Accounting Value per Share IO Biotech|IOBT - Company Book Value|Market Cap to Net Assets Ratio iobiotech.com|IOBT - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital IO Biotech, Inc.|IOBT - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio IO Biotech Inc.|IOBT - Company Debts|Debts to Book Value IO Biotech Inc|IOBT - Company Long-Term Liabilities|Short-Term Indebtedness IO Biotech|Intermediate Liquidity Ratio iobiotech.com
- earnings and market multiples details:
IOBT - Net Profit|Expected Net Income IO Biotech, Inc.|IOBT - P/E Multiple|Projected Price to Earnings Ratio IO Biotech Inc|IOBT - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation IO Biotech Inc|IOBT - Operating profit EBITDA|Net earnings per share (EPS TTM) IO Biotech|IOBT - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months iobiotech.com|IOBT - Net earnings per share growth this year|Expected net earnings per share growth next year IO Biotech, Inc.
Initial company analysis:IOBT, iobiotech.com
Mass-produced product of iobiotech.com

This metric captures the change in net income per share over the last twelve months relative to the preceding period. Analyzing the rolling annual growth of earnings per share allows for an assessment of business capitalization efficiency and the pace of yield scaling. The formula reveals the actual speed of profitability by neutralizing seasonal reporting distortions. For IO Biotech, Inc. (IOBT), such fluctuations reflect a stage of intensive investment in proprietary vaccines prior to the completion of final FDA trials.

Direct competitors

Earnings per share for the trailing year IBRX (immunitybio.com)|IMCR: Net earnings per share (EPS TTM)|JANX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Arcus Bio|Net earnings per share for the last 12 months Zymeworks Biopharmaceuticals (ZYME)|Earnings per share for the last twelve months Tango Therapeutics (TNGX)|Net earnings per share for the last 12 months iovance.com IOVA|Immatics - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Xencor Inc XNCR|CMPX - Earnings per share for the last twelve months|REPL (Replimune Inc.) - Earnings per share for the last 12 months|Lyell Immunopharma (LYEL) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months innate-pharma.com (IPHA)|Net earnings per share for the last 12 months PYXS|CGEN - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) HOWL (Werewolf Therapeutics, Inc.)|Earnings per share for the trailing year IMMX|ALX Oncology Holdings - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months cuebiopharma.com|pdsbiotech.com (PDSB) - Earnings per share for the last twelve months|Sonnet BioTherapeutics Holdings - Earnings per share for the trailing year|MAIA (MAIA Biotechnology) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) liminatuspharma.com|Earnings per share for the last twelve months LAVA Therapeutics N.V. (LVTX)|NXTC: Earnings per one share for the last 12 months|Leap Therapeutics - Net earnings per share for the last 12 months|Intensity Therapeutics Inc (INTS) - Net earnings per one share for the last twelve months|Sensei Bio - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters therivabio.com TOVX|gritstonebio.com (GRTS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Kineta Inc (KA)|Net earnings per share for the last 12 months NEXI|TSBX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VCNX|Earnings per share for the last twelve months HARP (harpoontx.com)